Javascript must be enabled to continue!
Innovative drug delivery methods for combating antimicrobial resistance
View through CrossRef
Antimicrobial resistance (AMR) poses a significant threat to global health, complicating the treatment of infectious diseases and leading to increased morbidity and mortality. Innovative drug delivery methods are emerging as critical strategies to combat AMR by enhancing the efficacy of existing antibiotics and facilitating the development of new therapeutic approaches. This paper explores the role of novel drug delivery systems in addressing AMR challenges. One of the primary approaches is the development of targeted drug delivery systems that improve the precision of antibiotic therapy. Nanotechnology has revolutionized this field, enabling the creation of nanoparticles and nanocarriers that can deliver drugs directly to infection sites, reducing systemic side effects and enhancing drug concentration at the target. These advanced delivery systems can be engineered to release antibiotics in a controlled manner, overcoming bacterial resistance mechanisms and minimizing the likelihood of resistance development. Another promising strategy involves the use of combination therapies delivered through innovative methods. By combining antibiotics with adjuvants or resistance-modifying agents, these systems can counteract resistance mechanisms and restore the effectiveness of existing drugs. For instance, drug delivery platforms that co-deliver antibiotics with inhibitors of bacterial efflux pumps or biofilm formation can enhance the treatment of resistant infections. The integration of smart drug delivery systems, which respond to environmental stimuli such as pH changes or specific bacterial enzymes, offers additional advantages. These systems can release antibiotics only in the presence of resistant bacteria, thereby reducing the overall exposure of bacteria to antibiotics and decreasing the risk of resistance. Innovative drug delivery methods also include the development of long-acting formulations and implants that provide sustained release of antibiotics over extended periods. Such systems reduce the frequency of dosing, improve patient adherence, and ensure consistent therapeutic levels, which are crucial for managing chronic infections and preventing resistance. In conclusion, innovative drug delivery methods are pivotal in the fight against AMR. By enhancing drug targeting, combining therapies, and utilizing smart and sustained-release systems, these approaches offer promising solutions to improve antibiotic efficacy and curb resistance. Continued research and development in this area are essential for advancing therapeutic strategies and ensuring effective management of infectious diseases in the face of rising antimicrobial resistance.
Keywords: Innovative, Drug Delivery Methods, Combating, Antimicrobial, Resistance.
Title: Innovative drug delivery methods for combating antimicrobial resistance
Description:
Antimicrobial resistance (AMR) poses a significant threat to global health, complicating the treatment of infectious diseases and leading to increased morbidity and mortality.
Innovative drug delivery methods are emerging as critical strategies to combat AMR by enhancing the efficacy of existing antibiotics and facilitating the development of new therapeutic approaches.
This paper explores the role of novel drug delivery systems in addressing AMR challenges.
One of the primary approaches is the development of targeted drug delivery systems that improve the precision of antibiotic therapy.
Nanotechnology has revolutionized this field, enabling the creation of nanoparticles and nanocarriers that can deliver drugs directly to infection sites, reducing systemic side effects and enhancing drug concentration at the target.
These advanced delivery systems can be engineered to release antibiotics in a controlled manner, overcoming bacterial resistance mechanisms and minimizing the likelihood of resistance development.
Another promising strategy involves the use of combination therapies delivered through innovative methods.
By combining antibiotics with adjuvants or resistance-modifying agents, these systems can counteract resistance mechanisms and restore the effectiveness of existing drugs.
For instance, drug delivery platforms that co-deliver antibiotics with inhibitors of bacterial efflux pumps or biofilm formation can enhance the treatment of resistant infections.
The integration of smart drug delivery systems, which respond to environmental stimuli such as pH changes or specific bacterial enzymes, offers additional advantages.
These systems can release antibiotics only in the presence of resistant bacteria, thereby reducing the overall exposure of bacteria to antibiotics and decreasing the risk of resistance.
Innovative drug delivery methods also include the development of long-acting formulations and implants that provide sustained release of antibiotics over extended periods.
Such systems reduce the frequency of dosing, improve patient adherence, and ensure consistent therapeutic levels, which are crucial for managing chronic infections and preventing resistance.
In conclusion, innovative drug delivery methods are pivotal in the fight against AMR.
By enhancing drug targeting, combining therapies, and utilizing smart and sustained-release systems, these approaches offer promising solutions to improve antibiotic efficacy and curb resistance.
Continued research and development in this area are essential for advancing therapeutic strategies and ensuring effective management of infectious diseases in the face of rising antimicrobial resistance.
Keywords: Innovative, Drug Delivery Methods, Combating, Antimicrobial, Resistance.
Related Results
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Knowledge and Beliefs about Antimicrobial drug resistance and its Implications in Future Prescribers
Knowledge and Beliefs about Antimicrobial drug resistance and its Implications in Future Prescribers
Background & Objective: Antimicrobial drug resistance is the ability of microorganisms to persist or grow in the presence of antimicrobial drugs designed to inhibit or kill the...
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
BACKGROUND
As of July 2020, a Web of Science search of “machine learning (ML)” nested within the search of “pharmacokinetics or pharmacodynamics” yielded over 100...
Advances in Coordination Compounds for the Drug Delivery System in the Human Circulatory System
Advances in Coordination Compounds for the Drug Delivery System in the Human Circulatory System
<b>Background:</b> Drug delivery is a significant and evolving research area that
relies on accurately quantifying drugs, particularly when developing drug delivery
sys...
Awareness Regarding Antimicrobial Use and Antimicrobial Resistance among Health Care Professionals and Lay Persons
Awareness Regarding Antimicrobial Use and Antimicrobial Resistance among Health Care Professionals and Lay Persons
BACKGROUND
Globally antimicrobial resistance is rising, and the Indian scenario is also similar to antimicrobial awareness. The study literature on awareness regarding antimi...
ANTIMICROBIAL RESISTANCE: REVIEW
ANTIMICROBIAL RESISTANCE: REVIEW
Antimicrobial resistance (AMR) is resistance of a microorganism to an antimicrobial that was originally effective for treatment of infections caused by it. Increasing clinical inci...
A REVIEW ON DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM
A REVIEW ON DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM
The purpose of this review was to select a promising drug delivery system for colon diseases. This review covers the development of Colon Targeted Drug Delivery System (CTDDS) usin...
Phenotypic and Molecular Characterization of the blaTEM Gene in Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae
Phenotypic and Molecular Characterization of the blaTEM Gene in Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae
Abstract
Introduction
There has been a notable rise in antibiotic resistance among enterobacteria. This issue is primarily attributed to the emergence of extended-spectrum beta-lac...

